FDA names permanent CDER director, boosts safety office

Share this article:
The FDA selected Gerald Dal Pan as director of the Office of Drug Safety in the Center for Drug Evaluation and Research (CDER). 
Dal Pan will report directly to the head of CDER, elevating the stature of the safety office to a level on par with the Office of New Drugs, which approves new medicines for sale, an FDA spokeswoman told MM&M.
Dal Pan joined the FDA in 2000. He most recently served as director, division of surveillance, research, and communication support, Office of Drug Safety in CDER, a position he has held since 2003. 
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.